In this emerging in the form of cooperation, biological medicine industry further extended to the biological agents in the form of outsourcing cooperation contract development and manufacturing organization (CDMO) mode, the CDMO from preclinical studies and clinical trials to commercial production stage and the enterprise research and development, procurement, production, such as depth of the whole supply chain system docking, provide enterprises with innovative technology research and development and large-scale production services, in the higher value-added technology output instead of the pure output capacity.
In 2018, the global Biologics Contract Development and Manufacturing Organization(CDMO) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Biologics Contract Development and Manufacturing Organization(CDMO) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biologics Contract Development and Manufacturing Organization(CDMO) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics
Market segment by Type, the product can be split into
Biologics Contract Development Services
Biologics Contract Manufacturing Services
Market segment by Application, split into
Big Pharma
Small Pharma
Generic Pharma
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Biologics Contract Development and Manufacturing Organization(CDMO) status, future forecast, growth opportunity, key market and key players.
To present the Biologics Contract Development and Manufacturing Organization(CDMO) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Biologics Contract Development and Manufacturing Organization(CDMO) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Biologics Contract Development and Manufacturing Organization(CDMO). Industry analysis & Market Report on Biologics Contract Development and Manufacturing Organization(CDMO) is a syndicated market report, published as Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Biologics Contract Development and Manufacturing Organization(CDMO) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.